1. Home
  2. Labeler Index
  3. Metuchen Pharmaceuticals, Llc
  4. 72384-751
  5. Product Images: Stendra

Product Images Stendra

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Stendra NDC 72384-751 by Metuchen Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The following structural formula for Avanafil occurs as white crystalline powder, molecular formula C23H26ClN7O3 and molecular weight of 483.95 and is slightly soluble in ethanol, practically insoluble in water, soluble in 0.1 mol/L hydrochloric acid. STENDRA, for oral administration, is supplied as oval, pale yellow tablets containing 50 mg, 100 mg, or 200 mg avanafil debossed with dosage strengths. In addition to the active ingredient, avanafil, each tablet contains the following inactive ingredients: mannitol, fumaric acid, hydroxypropylcellulose, low substituted hydroxypropylcellulose, calcium carbonate, magnesium stearate, and ferric oxide yellow. - stendra 01

The following structural formula for Avanafil occurs as white crystalline powder, molecular formula C23H26ClN7O3 and molecular weight of 483.95 and is slightly soluble in ethanol, practically insoluble in water, soluble in 0.1 mol/L hydrochloric acid. STENDRA, for oral administration, is supplied as oval, pale yellow tablets containing 50 mg, 100 mg, or 200 mg avanafil debossed with dosage strengths. In addition to the active ingredient, avanafil, each tablet contains the following inactive ingredients: mannitol, fumaric acid, hydroxypropylcellulose, low substituted hydroxypropylcellulose, calcium carbonate, magnesium stearate, and ferric oxide yellow. - stendra 01

Figure 1: Median Change from Baseline in Sitting Systolic Blood Pressure, Healthy Volunteers Day 4 - stendra 02

Figure 1: Median Change from Baseline in Sitting Systolic Blood Pressure, Healthy Volunteers Day 4 - stendra 02

Figure 2: Mean (SD) Change From Baseline in Standing Systolic Blood Pressure Over Time Following Administration of a Single Dose 200 mg Dose of STENDRA with Doxazosin - stendra 03

Figure 2: Mean (SD) Change From Baseline in Standing Systolic Blood Pressure Over Time Following Administration of a Single Dose 200 mg Dose of STENDRA with Doxazosin - stendra 03

Figure 3: Mean (SD) Change From Baseline in Standing Systolic Blood Pressure Over Time Following Administration of a Single Dose 200 mg Dose of STENDRA with Tamsulosin - stendra 04

Figure 3: Mean (SD) Change From Baseline in Standing Systolic Blood Pressure Over Time Following Administration of a Single Dose 200 mg Dose of STENDRA with Tamsulosin - stendra 04

Figure 4: Plasma Avanafil Concentrations (mean ± SD) Following a Single 50 mg or 200 mg STENDRA Dose - stendra 05

Figure 4: Plasma Avanafil Concentrations (mean ± SD) Following a Single 50 mg or 200 mg STENDRA Dose - stendra 05

This appears to be random text with no specific meaning or context. It is not available.*

PRINCIPAL DISPLAY PANELNDC 76299-320-85STENDRA(avanafil) tablets50 mgRx Only30 Tablets - stendra 07

PRINCIPAL DISPLAY PANELNDC 76299-320-85STENDRA(avanafil) tablets50 mgRx Only30 Tablets - stendra 07

PRINCIPAL DISPLAY PANELNDC 76299-321-85STENDRA(avanafil) tablets100 mgRx Only30 Tablets - stendra 08

PRINCIPAL DISPLAY PANELNDC 76299-321-85STENDRA(avanafil) tablets100 mgRx Only30 Tablets - stendra 08

PRINCIPAL DISPLAY PANELNDC 76299-322-85STENDRA(avanafil) tablets200 mgRx Only30 Tablets - stendra 09

PRINCIPAL DISPLAY PANELNDC 76299-322-85STENDRA(avanafil) tablets200 mgRx Only30 Tablets - stendra 09

This text appears to be a mix of characters, symbols, numbers, and product names. It is difficult to understand and seems to be illegible due to errors. Therefore, the description cannot be provided.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.